Anti-Ferritin Light Chain 抗体 [EPR5259] (ab109019)


  • 製品名Anti-Ferritin Light Chain antibody [EPR5259]
    Ferritin Light Chain 一次抗体 製品一覧
  • 製品の詳細
    Rabbit monoclonal [EPR5259] to Ferritin Light Chain
  • アプリケーション適用あり: WB, IP, ICCmore details
    適用なし: Flow Cyt or IHC-P
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    A synthetic peptide corresponding to residues near the N-terminus of Human Ferritin Light Chain.

  • ポジティブ・コントロール
    • Human fetal liver, HepG2 and HeLa cell lysates.
  • 特記事項

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.



Our Abpromise guarantee covers the use of ab109019 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/1000 - 1/10000. Predicted molecular weight: 20 kDa.
IP 1/10 - 1/100.
ICC 1/100 - 1/250.
  • 追加情報Is unsuitable for Flow Cyt or IHC-P.
  • ターゲット情報

    • 機能Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney.
    • 関連疾患Defects in FTL are the cause of hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]. It is an autosomal dominant disease characterized by early-onset bilateral cataract. Affected patients have elevated level of circulating ferritin. HHCS is caused by mutations in the iron responsive element (IRE) of the FTL gene.
      Defects in FTL are the cause of neurodegeneration with brain iron accumulation type 3 (NBIA3) [MIM:606159]; also known as adult-onset basal ganglia disease. It is a movement disorder with heterogeneous presentations starting in the fourth to sixth decade. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild nonprogressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels.
    • 配列類似性Belongs to the ferritin family.
      Contains 1 ferritin-like diiron domain.
    • Information by UniProt
    • 参照データベース
    • 別名
      • Ferritin L chain antibody
      • Ferritin L subunit antibody
      • Ferritin light chain antibody
      • Ferritin light polypeptide antibody
      • ferritin light polypeptide like 3 antibody
      • FRIL_HUMAN antibody
      • FTL antibody
      • LFTD antibody
      • NBIA 3 antibody
      • NBIA3 antibody
      see all

    Anti-Ferritin Light Chain antibody [EPR5259] 画像

    • All lanes : Anti-Ferritin Light Chain antibody [EPR5259] (ab109019) at 1/1000 dilution

      Lane 1 : Human fetal liver lysate
      Lane 2 : HepG2 cell lysate
      Lane 3 : HeLa cells lysate

      Lysates/proteins at 10 µg per lane.

      Predicted band size : 20 kDa

    Anti-Ferritin Light Chain antibody [EPR5259] (ab109019) 使用論文

    This product has been referenced in:
    • Wu T  et al. Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway. PLoS One 11:e0149361 (2016). WB, IHC, ICC/IF ; Human . Read more (PubMed: 26871431) »

    See 1 Publication for this product

    Product Wall

    Application Western blot
    Sample Mouse Tissue lysate - whole (Liver)
    Gel Running Conditions Reduced Denaturing (4-20%)
    Loading amount 50 µg
    Specification Liver
    Blocking step Rockland fluorescent blocking buffer as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 50% · Temperature: 25°C

    Abcam user community

    Verified customer

    投稿 Jul 07 2015